one
greatest
challeng
modern
immunolog
develop
effect
vaccin
divers
diseas
cancer
hepat
acquir
immun
defici
syndrom
aid
convent
viral
bacteri
vaccin
consist
attenu
nonvirul
strain
pathogen
organ
stock
inactiv
heat
chemic
treatment
irradi
howev
method
carri
inher
risk
vaccin
may
induc
diseas
due
incomplet
inactiv
appear
virul
revert
attenu
strain
modern
molecular
biolog
offer
altern
method
produc
safe
effect
microbi
vaccin
includ
express
recombin
antigen
epitop
nonpathogen
carrier
vaccinia
viru
approach
valid
strongli
immunogen
viral
bacteri
epitop
less
promis
tumor
system
involv
less
welldefin
weakli
immunogen
tumor
antigen
thu
develop
effect
tumor
vaccin
still
pose
signific
challeng
modern
immunologist
one
novel
excit
approach
tumor
vaccin
develop
involv
network
hypothesi
origin
propos
jern
view
immun
system
antibodi
interact
nomin
antigen
also
antibodi
molecul
cours
immun
respons
antibodi
variabl
region
contain
two
import
site
necessari
interact
occur
includ
paratop
antigen
combin
site
idiotop
immunogen
site
bound
paratop
antibodi
molecul
collect
uniqu
idiotop
born
individu
antibodi
collect
refer
idiotyp
id
molecul
immun
system
thu
view
network
interact
element
express
uniqu
id
capabl
elicit
specif
antiid
respons
exampl
antigen
may
activ
popul
b
cell
express
antibodi
id
abl
bear
distinct
id
determin
capabl
bind
ag
paratop
fig
id
determin
ab
also
immunogen
stimul
second
popul
lymphocyt
express
ab
molecul
term
antiid
antibodi
likewis
stimul
third
popul
lymphocyt
express
antiantiid
antibodi
recogn
bind
subset
respons
ab
also
bind
origin
antigen
thu
least
portion
respons
possess
capac
stimul
antigenspecif
immun
respons
id
cascad
may
play
posit
neg
regulatori
role
respons
nomin
antigen
particular
interest
discuss
id
antiid
reagent
may
use
induc
specif
immun
respons
absenc
nomin
antigen
featur
id
network
lend
develop
effect
vaccin
would
elimin
need
purifi
larg
quantiti
poorli
defin
poorli
immunogen
tumor
antigen
advent
ofhybridoma
technolog
result
abil
produc
larg
quantiti
pure
monoclon
antibodi
desir
specif
provid
quantum
leap
technolog
id
vaccin
develop
immun
network
hypothesi
origin
propos
jern
limit
b
lymphocyt
secret
antibodi
howev
mani
report
implic
antigenspecif
idspecif
regulatori
lymphocyt
idbas
regul
immun
respons
find
suggest
idspecif
cell
interact
b
cell
regul
id
antigenspecif
immun
respons
iddirect
bt
lymphocyt
cooper
conceiv
gener
physiolog
phenomenon
recognit
id
determin
cell
confer
ad
level
complex
network
regul
sinc
bt
lymphocyt
interact
may
either
inhibitori
stimulatori
effect
particular
antigenspecif
b
cell
depend
spectrum
oflymphokin
produc
cell
ad
dimens
cell
involv
idbas
regul
contradict
basic
tenet
immun
network
theori
instead
may
supplement
global
manner
use
howev
exquisit
specif
larg
scale
product
potenti
monoclon
antibodi
make
method
choic
vaccin
develop
corn
tabla
id
network
activ
antibodi
alon
virusinduc
tumorassoci
antigen
virus
associ
infecti
diseas
hiv
human
immunodefiei
viru
fmdv
foot
mouth
diseas
viru
vee
venezuelan
equin
encephalomyel
viru
jev
japanes
enceph
viru
tgev
transmiss
gastroenter
coronaviru
activ
ld
network
id
ab
antiid
antibodi
b
respons
detect
respons
detect
nr
report
r
protect
protect
increas
pathogen
nr
report
clonal
inject
antibodi
ab
see
column
baskinpowellsrinivaseuiottlamon
antigenindepend
regul
immun
respons
mon
strategi
gener
antiepitop
monoclon
antibodi
abl
associ
protect
respons
host
eg
virusneutr
ab
use
immunogen
elicit
antiid
antibodi
ideal
id
born
ab
locat
suffici
near
antigen
combin
site
antibodi
paratopeassoci
interspeci
crossreact
abl
induc
second
popul
antiid
antibodi
gener
manner
may
present
complementari
threedimension
conform
suffici
similar
origin
viral
epitop
defin
ab
exposur
antiid
alon
could
conceiv
mimic
effect
exposur
viral
epitop
virusinduc
antigen
none
potenti
neg
consequ
idea
appeal
regard
develop
altern
vaccin
strategi
sinc
antiid
could
potenti
supersed
antigen
induct
id
antigenspecif
respons
approach
obvious
attract
consid
vaccin
hiv
hepat
pathogen
employ
convent
vaccin
contain
kill
attenu
viru
may
riski
laboratori
investig
antigenindepend
modul
immun
monoclon
antibodi
viral
nonvir
antigen
one
system
examin
antibodyinduc
immun
respons
moloney
murin
leukemia
virusinduc
cell
surfac
antigen
mcsa
also
investig
antigenindepend
immun
respons
welldefin
id
associ
balbc
immun
respons
hapten
dnp
review
describ
id
antigenbind
specif
sera
mice
inject
unmodifi
homolog
monoclon
antibodi
absenc
carrier
molecul
adjuv
antigen
although
natur
antigen
differ
l
schemat
represent
id
network
antigen
ag
induc
recogn
lymphocyt
express
antibodi
bear
id
abl
abl
induc
recogn
lymphocyt
express
antiid
antibodi
subset
design
ab
recogn
also
react
origin
ag
circuit
may
share
idiotop
abl
subset
design
b
l
abl
etc
repres
parallel
set
may
share
idiotop
ab
ab
distinct
bind
specif
likewis
subset
design
recogn
also
bind
ab
may
share
idiotop
subset
repres
parallel
set
characterist
describ
viral
vs
hapten
common
featur
observ
immun
respons
gener
introduct
monoclon
antibodi
within
id
system
experi
passiv
immun
abl
activ
id
network
fig
elicit
respons
portion
latter
exhibit
specif
antigen
abl
mice
passiv
immun
antiid
antibodi
product
abl
also
observ
experi
mcsa
system
result
ab
respons
prove
effect
protect
anim
tumor
develop
upon
subsequ
challeng
live
viru
addit
show
antigenindepend
modul
immun
dnp
moloney
murin
sarcomaleukemia
viru
complex
mmusv
mmulu
thymusdepend
mmuswmmulv
compos
mmusv
replicationdefect
retroviru
transform
cell
induc
tumor
format
mmulv
helper
viru
necessari
mmusv
replic
inject
mmusvmmulv
mice
induc
local
sarcoma
spontan
regress
immunocompet
host
regress
event
depend
upon
specif
humor
cellmedi
immun
respons
direct
antigen
encod
helper
viru
laboratori
isol
character
three
hybridoma
clone
secret
monoclon
igm
k
antibodi
bind
mmuswmmulvinfect
cell
monoclon
antibodi
mab
bind
cytoplasm
cell
surfac
friendmoloneyrausch
groupspecif
antigen
determin
elisa
immunofluoresc
immunoelectron
microscopi
reveal
antibodi
bind
virusinfect
cell
surfac
bud
matur
viru
particl
agreement
immunoelectron
microscopi
mab
unabl
neutral
viru
activ
complementmedi
cellmedi
cytotox
infect
cell
suggest
antibodi
specif
cell
surfac
antigen
test
hypothesi
obtain
mutant
clone
mmulv
produc
infecti
viru
lack
gene
transmembran
leader
sequenc
thu
produc
glycosyl
cell
surfac
cell
transfect
provir
dna
mutant
wildtyp
mmulv
cell
express
cytoplasm
antigen
detect
immunofluoresc
one
igm
mab
howev
cell
transfect
wildtyp
provir
dna
contain
cell
surfac
suscept
complementmedi
lysi
induc
antibodi
data
provid
direct
evid
cell
surfac
target
antibodi
epitop
contain
within
vitro
character
mab
summar
tabl
due
vitro
reactiv
mab
mcsa
attempt
determin
whether
could
exhibit
antitumor
activ
vivo
balbc
mice
receiv
intramuscular
inocul
oncogen
dose
mmusvmmulv
twice
week
thereaft
mice
inocul
intraperiton
either
mcsaspecif
mab
isotypematch
control
mab
salin
tumor
size
measur
site
viru
inject
everi
day
repres
experi
shown
figur
two
mcsaspecif
mab
demonstr
pronounc
vivo
antitumor
activ
provid
complet
nearli
complet
protect
tumor
develop
effect
due
nonspecif
activ
igm
mab
sinc
mice
treat
control
mab
protect
tumor
develop
vivo
protect
effect
mcsaspecif
igm
partial
depend
presenc
function
cell
athym
nunu
euthym
nu
mice
inocul
viru
treat
mab
sarcoma
develop
growth
could
inhibit
surviv
time
increas
nunu
mice
receiv
mmusvspecif
igm
data
shown
howev
nunu
mice
eventu
die
overwhelm
tumor
burden
euthym
litterm
receiv
ident
treatment
recov
complet
vivo
experi
demonstr
mcsaspecif
igm
mab
could
exhibit
antitumor
activ
vivo
result
reveal
mechan
protect
sever
possibl
mechan
direct
mechan
protec
baskinpowellsrinivaselliottlamon
antigenindepend
regul
immun
respons
tion
might
simpl
neutral
viru
inoculum
thu
prevent
infect
transform
cell
vivo
howev
state
previous
none
mab
capabl
neutral
viru
test
vitro
therefor
possibl
unlik
explain
vivo
antitumor
activ
thu
consid
mechan
direct
virusinfect
cell
rather
free
viru
particl
mab
known
exhibit
complementand
cellmedi
lysi
infect
cell
vitro
see
tabl
possibl
effector
arm
immun
respons
involv
follow
bind
mab
target
antigen
infect
cell
lead
lysi
tumor
cell
mechan
specif
passiv
activ
antigenspecif
lymphocyt
requir
gener
either
compon
complement
cascad
effector
cell
capabl
mediat
antibodydepend
cell
cytotox
therefor
investig
hypothesi
igm
pc
h
l
repres
h
l
chain
composit
mab
determin
elisa
mab
assay
reactiv
elisa
posit
neg
weakli
reactiv
one
experi
dnp
react
weakli
od
howev
titer
equal
igm
concentr
lower
subsequ
experi
dnp
neg
modifi
pc
phosphorylcholin
spleen
well
correspond
e
effector
cell
experi
treat
trypsin
prior
assay
b
four
balbc
micegroup
inocul
mmusv
day
previous
inject
intraperiton
twice
weekli
ltg
igm
ascit
fluid
last
treatment
day
viru
inject
fraction
experi
previous
shown
specif
cytotox
spleen
ceil
balbc
mice
day
longer
viru
inject
mediat
nont
cell
r
reduct
compar
pbstreat
group
extrapol
remain
target
cell
data
combin
differ
microtit
plate
number
remain
target
cell
well
normal
control
well
contain
target
cell
medium
n
effector
cell
concentr
mean
sem
normal
target
cell
remain
effector
concentr
pbstreat
estim
student
test
compar
pbstreat
group
effector
cell
concentr
modifi
antigenspecif
activ
immun
system
result
passiv
immunotherapi
mcsaspecif
igm
mab
sinc
function
cell
requir
achiev
complet
tumor
resist
mab
therapi
propos
mcsaspecif
monoclon
antibodi
induc
antigenspecif
cellmedi
immun
respons
vivo
test
hypothesi
mice
inocul
viru
without
subsequ
mab
administr
describ
thirti
day
viru
inject
spleen
cell
virusinocul
mice
assay
cytotox
activ
mmusvtransform
target
cell
expect
spleen
cell
virusinocul
mice
lytic
tumor
cell
vitro
surprisingli
spleen
cell
virusinocul
mice
subsequ
given
mab
inject
exhibit
cytotox
activ
compar
mice
inocul
viru
tabl
cytotox
activ
effector
cell
due
passiv
adsorb
monoclon
antibodi
sinc
exposur
splenocyt
trypsin
reduc
abil
kill
transform
target
data
suggest
administr
mcsaspecif
monoclon
igm
activ
specif
immun
respons
result
gener
tumorspecif
cytotox
effector
cell
vivo
addit
cytotox
effector
cell
b
cell
helper
cell
import
normal
immun
respons
mmusvmmulv
thu
hypothes
b
cell
extens
helper
cell
activ
exposur
mcsaspecif
igm
mab
repres
ab
test
hypothesi
examin
mcsaspecif
antibodi
respons
sera
mice
treat
ab
mice
inocul
viru
without
subsequ
igm
abl
administr
describ
observ
tumor
develop
variou
time
point
cours
tumor
develop
regress
sera
collect
examin
titer
mcsaspecif
antibodi
elisa
employ
isotypespecif
secondari
reagent
abl
distinguish
passiv
administ
igm
antibodi
antigenspecif
antibodi
produc
vivo
baskinpoweusrinivaselliottlamon
antigenindepend
regul
immun
respons
result
serolog
assay
parallel
cellular
assay
describ
ie
higher
titer
mcsaspecif
nonigm
antibodi
found
sera
mice
receiv
igm
mab
inject
follow
viru
inocul
compar
anim
inocul
viru
fig
mcsaspecif
serum
antibodi
induc
igm
abl
administr
predominantli
isotyp
minor
contribut
isotyp
presenc
mcsaspecif
particularli
intrigu
sinc
isotyp
almost
complet
absent
normal
antibodi
respons
viru
challeng
balbc
mice
result
suggest
administr
igm
ab
activ
antigenspecif
b
cell
vivo
secret
antigenspecificantibodi
isotyp
distinct
origin
abl
one
interest
excit
find
studi
occur
serendipit
initi
serolog
studi
mice
examin
follow
inocul
viru
without
subsequ
abi
treatment
howev
mice
receiv
abl
treatment
absenc
viru
inocul
therefor
experi
expand
includ
group
mice
treat
fashion
thu
four
group
mice
examin
presenc
mcsaspecif
serum
antibodi
titer
normal
inocul
viru
inocul
viru
follow
igm
abl
treatment
treat
igm
abl
absenc
viru
inocul
expect
group
undetect
titer
mcsaspecif
antibodi
group
ii
measur
titer
predominantli
igm
antibodi
group
iii
elev
titer
mcsaspecif
antibodi
surprisingli
mcsaspecif
titer
sera
group
iv
mice
essenti
ident
found
group
iii
suggest
titer
seen
group
iii
result
primarili
exposur
igm
abl
independ
exposur
viru
fig
thu
inject
igm
ab
vaccin
effect
result
activ
antigenspecif
b
cell
vivo
difficult
envis
inject
antigenspecif
antibodi
ab
result
activ
b
cell
specif
antigen
unless
one
invok
id
network
discuss
hypothes
abl
inject
initi
id
cascad
abl
detect
sever
antibodi
specif
sera
treat
mice
antiid
antibodi
bind
specif
id
determin
inject
ab
antiantiid
antibodi
bind
specif
id
determin
abl
subset
bind
also
nomin
antigen
case
mcsa
ab
would
repres
increas
titer
mcsaspecif
found
sera
ab
mice
therefor
sera
examin
titer
elisa
use
plate
coat
immun
abl
isotypematch
control
mab
sinc
coat
mab
igm
use
igg
subclassspecif
secondari
reagent
detect
titer
high
titer
found
group
iii
viru
plu
abl
group
iv
ab
detect
quantiti
group
ii
fig
thu
first
step
ablinduc
id
cascad
product
confirm
detect
employ
elisa
plate
coat
monoclon
recogn
common
idiotop
present
panel
mcsaspecif
igm
mab
hybridoma
secret
produc
immort
b
cell
mous
immun
igm
mab
screen
bind
sever
differ
igm
mab
identifi
abil
bind
specif
mcsaspecif
igm
mab
unrel
igm
mab
dispar
specif
sera
four
group
mice
describ
assay
titer
group
iii
viru
plu
abl
group
iv
abl
sera
display
signific
titer
tabl
titer
consist
isotyp
thu
second
step
ablinduc
id
cascad
product
confirm
seri
studi
fig
tabl
abl
fig
detect
sera
mice
immun
igm
ab
believ
data
constitut
first
descript
complet
id
network
induc
exposur
antigenspecif
mab
absenc
appar
exposur
nomin
antigen
addit
serolog
observ
also
observ
prime
cellular
respons
tabl
would
suggest
id
manipul
immun
respons
may
serv
potent
rout
vaccin
howev
ab
provid
protect
therapeut
manner
fig
fail
gener
protect
prophylact
manner
data
shown
even
though
prior
immun
abl
induc
humor
cellular
respons
follow
demonstr
id
cascad
activ
ab
examin
effect
administr
subsequ
immun
respons
mice
immun
intraperiton
vari
dose
rs
suspend
salin
without
adjuv
sera
analyz
sera
assay
figur
assay
antibodi
use
elisa
plate
coat
purifi
monoclon
result
present
mean
sem
triplic
sera
time
point
day
day
viru
inocul
nm
normal
mous
sera
musv
sera
mice
inocul
viru
day
musv
sera
mice
inocul
viru
day
follow
igm
day
tg
mouseinject
sera
mice
inject
igm
viru
inocul
isotyp
isotyp
probe
elisa
total
isotyp
except
igg
modifi
bind
abl
bind
mcsa
mice
immun
increas
quantiti
elev
titer
serum
undetect
sera
nonimmun
mice
igm
domin
isotyp
also
detect
fig
sera
screen
ab
antibodi
igm
iggl
isotyp
detect
fig
data
show
immun
activ
id
network
result
product
abl
similar
result
describ
earlier
ab
immun
serolog
result
follow
ab
immun
similar
mark
differ
seen
induct
protect
immun
describ
ab
mice
display
high
titer
antigenspecif
antibodi
well
increas
cytotox
cellular
activ
resist
tumor
develop
naiv
control
mice
mice
immun
prior
viru
challeng
howev
effect
immun
achiev
mice
experienc
reduct
tumor
size
peak
tumor
develop
day
viru
challeng
overal
reduct
tumor
load
entir
cours
experi
compar
nonimmun
euthym
control
fig
protect
effect
appear
celldepend
sinc
athym
nunu
mice
immun
protect
sarcoma
growth
appar
decreas
tumor
size
athym
mice
day
due
death
mice
baskinpowellsrinivaselliottlamon
antigenlndepend
regul
immun
respons
fig
effect
immun
subsequ
tumor
develop
euthym
athym
mice
either
immun
five
inject
pg
immun
mice
rest
day
follow
last
inject
challeng
mmusv
mmulv
intramuscularli
right
thigh
thigh
diamet
measur
day
result
present
geometr
mean
increas
thigh
diamet
group
mean
sem
geometr
mean
percent
control
tumor
burden
euthym
mice
normal
mice
mice
repres
signific
reduct
p
student
test
appar
decreas
mean
tumor
size
day
athym
mice
due
death
mice
largest
tumor
time
true
reduct
tumor
size
note
athym
mice
die
tumor
growth
day
wherea
euthym
mice
show
complet
regress
tumor
day
modifi
largest
tumor
due
tumor
regress
athym
mice
die
day
viru
challeng
nu
litterm
complet
recov
tumor
develop
result
indic
cell
involv
necessari
resist
tumor
develop
mice
separ
experi
mab
administ
mice
inocul
oncogen
dose
viru
ie
tumor
develop
result
increas
tumor
size
compar
untreat
control
mice
mechan
increas
suscept
tumor
develop
unclear
may
due
competit
interact
virusinduc
tumor
antigen
perhap
interact
id
b
cell
andor
cell
prevent
respons
act
antigen
display
tumor
cell
therefor
administr
effect
prophylact
therapeut
convers
true
ab
administr
see
final
wish
determin
alter
adult
id
repertoir
would
effect
tumor
suscept
base
work
vakil
et
al
inject
abl
neonat
balbc
mice
attempt
clonal
delet
lymphocyt
bound
id
reagent
mice
rest
adulthood
week
challeng
oncogen
dose
viru
result
quit
surpris
mice
neonatatli
inject
attempt
elimin
id
lymphocyt
experienc
signific
chang
suscept
tumor
develop
compar
control
litterm
control
tumor
burden
p
id
lymphocyt
inde
elimin
data
suggest
altern
id
activ
upon
viru
challeng
result
normal
resist
tumor
develop
howev
mice
inject
ab
attempt
elimin
antiid
lymphocyt
develop
much
larger
tumor
control
litterm
control
tumor
burden
p
data
suggest
elimin
antiid
lymphocyt
render
mice
less
abl
effect
respond
viru
challeng
surpris
sinc
antiid
lymphocyt
would
expect
exert
feedback
regulatori
effect
antitumor
respons
thu
elimin
would
allow
antitumor
respons
proceed
vigor
seem
therefor
antiid
lymphocyt
play
import
posit
rather
neg
regulatori
role
antitumor
respons
least
data
emphas
import
balanc
id
cascad
respons
viru
challeng
although
mmusvmmulvspecif
antibodi
respons
induc
inject
abl
neither
antigen
id
antibodi
respond
antigen
well
character
order
fulli
examin
antigenspecif
b
cell
activ
unmodifi
ab
decid
investig
possibl
find
mmusvmmulv
system
could
also
extend
welldefin
id
system
examin
respons
haptenspecif
monoclon
igm
bear
id
id
antibodi
ab
id
mab
repres
antiid
id
previous
character
term
express
germlin
vh
gene
famili
associ
reactiv
mice
passiv
immun
unmodifi
dnpspecif
igm
ab
absenc
exogen
adjuv
antigen
sera
examin
induc
baskinpowellsrinivaselliottlamon
antigenlndepend
regul
immun
respons
detect
elisa
plate
coat
immun
ab
particular
antibodi
given
numer
design
follow
immun
sera
normal
mous
sera
control
subsequ
incub
igg
subclassspecif
secondari
reagent
passiv
immun
unmodifi
dnpspecif
igm
abl
found
produc
measur
respons
id
specif
induc
examin
detail
evalu
immun
nonimmun
serum
bind
panel
antibodi
repres
major
id
famili
vh
gene
famili
induc
found
restrict
individu
id
present
immun
igm
tabl
fig
idspecif
antibodi
titer
dnpspecif
igm
mab
greater
howev
sera
test
panel
idiotyp
distinct
monoclon
antibodi
igg
titer
significantli
differ
found
normal
serum
respons
antiisotyp
sinc
immun
sera
bind
igm
mab
panel
exquisit
specif
serum
respons
dnpspecif
igm
inject
mice
indic
respons
direct
individu
idiotop
inject
antibodi
clear
present
time
idiotop
contribut
id
sinc
serum
recogn
antibodi
panel
serum
respons
probe
found
partial
dosedepend
increas
quantiti
inject
dnpspecif
igm
data
shown
induct
also
requir
presenc
function
cell
athym
nude
euthym
mice
inject
ident
quantiti
dnpspecif
igm
total
serum
igg
antiid
titer
examin
elisa
immun
sera
euthym
mice
gener
titer
serum
antiid
approxim
higher
immun
sera
athym
mice
receiv
quantiti
dnpspecif
igm
fig
serum
titer
antiid
athym
anim
significantli
differ
nonimmun
control
detect
employ
elisa
assay
plate
coat
monoclon
recogn
id
sera
dnpspecif
igminject
mice
analyz
presenc
examin
parallel
antibodi
mice
undergo
respons
could
also
shown
produc
gener
respons
dnpspecif
igm
inject
bound
specif
bind
idiotyp
unrel
k
mab
could
demonstr
fig
b
addit
subset
specif
antigen
abl
also
detect
fig
thymu
depend
antiid
respons
athym
nunu
euthym
nu
mice
inject
twice
gg
serum
antiid
assay
antibodi
bind
titer
serum
antmd
nu
mice
inject
significantli
higher
nunu
mice
immun
parallel
unimmun
control
plate
probe
total
serum
igg
data
repres
log
mean
sd
endpoint
titer
individu
sera
group
modifi
nm
normal
mous
sera
imm
immun
sera
baskinpowellsrinivaselliottlamon
antigenindepend
regul
immun
respons
determin
abl
contain
within
set
antiid
bind
antibodi
sever
haptenbsa
conjug
includ
acetyl
np
ox
dnp
dextranbsa
test
abil
compet
bind
serum
coat
plate
id
system
mice
inject
dnp
specif
monoclon
antibodi
gener
igm
abl
antibodi
inhibit
bind
elisa
plate
dnpbsa
lesser
extent
oxbsa
npbsa
fig
la
igg
compon
respons
restrict
dnpbsa
abl
inhibit
bind
serum
abl
plate
fig
l
b
experi
reveal
addit
homolog
antibodi
produc
greatest
degre
inhibit
suggest
signific
fraction
induc
ag
specif
dnp
parallel
set
howev
find
indic
portion
dnp
respons
design
abl
inde
subset
defin
bind
wherea
abl
respons
could
observ
euthym
mice
measur
respons
detect
nude
mice
receiv
ident
quantiti
unmodifi
dnpspecif
igm
data
shown
thu
step
ablinduc
id
cascad
product
confirm
id
system
data
also
demonstr
antigenindepend
induct
thymusdepend
previou
studi
shown
inject
dnpspecif
igm
abl
absenc
adjuv
ag
induc
includ
abl
result
suggest
prove
antiid
antibodi
induc
capabl
mimick
ag
could
therefor
elicit
agspecif
respons
investig
id
interact
system
mice
inject
id
mab
repres
antiid
induc
igm
respons
detect
thymusdepend
idiotyp
specif
fig
b
serum
respons
abl
detect
igm
isotyp
specif
igg
respons
observ
addit
inject
mice
induc
celldepend
igm
respons
hapten
dnp
np
ox
fig
specif
serum
ab
bind
mice
evalu
antigen
inhibit
bind
serum
abl
dnpbsa
inhibit
dnplysin
wherea
equival
concentr
lysin
alon
inhibitori
effect
agreement
find
mmuswmmulv
system
shown
activ
id
network
accomplish
inject
either
ab
sera
mice
inject
id
mab
contain
antiantiid
antibodi
result
network
perturb
gener
antigenspecifc
antibodi
ab
produc
absenc
ag
exposur
baskinpowellsrinivaselliottlamon
antigenindepend
regul
immun
respons
antibodyinduc
modul
immun
novel
immunotherapeut
strategi
capac
boost
antigenspecif
iramun
respons
virusinduc
tumorassoci
antigen
viral
induc
cell
surfac
epitop
associ
infecti
diseas
immun
antibodi
alon
potenti
supersed
antigen
induct
id
antigenspecif
respons
circumv
risk
exposur
infecti
agent
idea
util
antiid
place
convent
antigen
altern
vaccin
strategi
origin
propos
nisonoff
lamoyi
note
antigen
antiid
may
sometim
share
relat
epitop
subsequ
report
also
broaden
classif
antiid
includ
etc
order
describ
detail
juxtaposit
ab
antigen
regard
idiotop
antigen
bind
specif
great
deal
attent
focus
internalimag
antiid
sinc
antibodi
propos
mimic
immunolog
properti
antigen
consid
primari
candid
antiid
vaccin
internalimag
concept
may
mislead
howev
sinc
term
impli
stereochem
ident
antiid
nomin
antigen
furthermor
nonintern
imag
shown
induc
antigenspecif
respons
thu
particip
function
signific
id
interact
recommend
use
term
network
antigen
suggest
et
al
may
therefor
appropri
way
describ
epitop
present
antiid
antibodi
varieti
differ
antiid
antibodi
may
thu
potenti
repres
construct
viral
antigen
nonvirul
nonprolifer
nonetheless
antigen
capabl
produc
virusspecif
immun
respons
absenc
antigen
concentr
effort
investig
antibodyinduc
immun
respons
use
mcsa
hapten
dnp
associ
distinct
id
observ
common
featur
immun
respons
gener
introduct
monoclon
antibodi
within
id
system
find
demonstr
immun
balbc
mice
monoclon
igm
specif
either
mcsa
dnp
ie
abl
activ
function
id
network
result
product
sera
also
found
contain
antigenspecif
antibodi
abl
also
demonstr
immun
also
activ
id
network
thu
propos
id
network
may
activ
either
ab
lead
product
antigenspecif
abl
respons
experi
inject
unmodifi
monoclon
ab
occur
absenc
exogen
adjuv
antigen
eg
viru
dnp
indic
nativ
antibodi
alon
suitabl
effect
immunogen
thymu
depend
immun
respons
observ
vitro
vivo
reflect
immun
network
activ
protect
experi
respect
appar
id
system
indic
cell
import
compon
antigen
iddirect
immun
respons
iddirect
celi
interact
result
antigenindepend
gener
abl
conceiv
occur
one
mechan
current
paradigm
cell
recognit
involv
antigen
present
cell
receptor
antigenpres
cell
case
th
cell
occur
context
major
histocompat
mhc
class
ii
antigen
thu
extern
antigen
present
process
peptid
antigenpres
groov
cell
surfac
mhc
class
ii
molecul
configur
allow
joint
recognit
antigen
self
mhc
cell
receptor
trigger
th
cell
function
helper
cell
whether
antigen
process
present
requir
tdepend
id
id
respons
known
would
involv
proteolyt
cleavag
antibodi
molecul
present
peptid
contain
id
baskinpowellsrinivaselliottlamon
antigenindepend
regul
immun
respons
might
particularli
relev
tdepend
antiid
respons
induc
antibodi
ab
igm
igm
fcr
describ
helper
cell
implic
function
involv
cell
help
thymusdepend
antibodi
respons
final
altern
fc
receptor
involv
would
induc
antibodi
could
bound
antigenpres
cell
fc
receptor
subsequ
cell
recognit
might
involv
side
side
recognit
id
antibodi
mhc
present
cell
fig
among
altern
one
would
predict
syngen
restrict
tdepend
id
respons
first
last
altern
two
previou
report
indic
lack
syngen
restrict
tdepend
id
respons
report
describ
lack
syngen
restrict
cell
respons
induc
monoclon
antit
cell
antibodi
express
antiid
exact
manner
b
cell
interact
one
anoth
still
present
unknown
activ
id
network
previous
describ
sever
viru
induc
tumorassoci
antigen
system
simian
viru
tag
system
balbc
mice
inject
mixtur
antiid
reactiv
mab
specif
differ
epitop
tag
suppress
tumor
format
cell
system
mice
inject
monoclon
antiid
induc
antibodi
compon
abl
recogn
tag
share
id
determin
abl
similarli
balbc
mice
inject
monoclon
antiid
specif
antifelin
leukemia
viru
felv
develop
respons
contain
low
level
antifelv
antibodi
mous
mammari
tumor
viru
mmtv
system
abl
recogn
share
determin
tumor
cell
line
envelop
mmtv
use
gener
monoclon
mice
inject
induc
mmtvspecif
antibodi
tumorspecif
cytotox
lymphocyt
howev
one
two
antiiri
examin
induc
protect
immun
tumor
growth
activ
id
network
also
describ
nontumor
viru
system
associ
infecti
diseas
mice
inject
recogn
common
id
found
antibodi
specif
hepat
b
surfac
ag
hbsag
gener
antibodi
reactiv
hbsag
absenc
antigen
antibodi
induc
inject
antiid
like
abl
express
interspeci
id
abl
recogn
groupspecif
determin
hbsag
preimmun
chimpanze
elicit
respons
protect
anim
infect
challeng
infecti
hepat
viru
reoviru
system
monoclon
antibodi
specif
neutral
epitop
type
reoviru
hemagglutinin
use
gener
syngen
monoclon
antiid
balbc
mice
inject
purifi
antiid
absenc
viral
antigen
exposur
elicit
antiantiid
respons
specif
immun
antiid
ab
compon
abl
bind
neutral
reoviru
type
prepar
matern
immun
mice
antiid
protect
neonat
challeng
potenti
lethal
dose
reoviru
type
caus
enceph
molecular
mimicri
reoviru
ha
antiid
system
found
relat
region
primari
amino
acid
sequenc
homolog
observ
two
protein
rabi
polioviru
system
immun
respect
led
product
contain
virusneutr
ab
antibodi
howev
protect
effect
challeng
lethal
dose
viru
observ
anim
protect
effect
note
howev
member
belong
viral
famili
studi
suggest
mani
antiid
gener
capabl
mimick
viral
epitop
virusinduc
antigen
appar
absenc
exposur
nomin
antigen
find
well
report
id
network
activ
viral
system
summar
tabl
although
virus
belong
distinct
famili
differ
genet
composit
protein
structur
replic
patholog
number
comparison
note
regard
id
network
activ
induct
protect
immun
agreement
observ
antibodyinduc
immun
respons
hapten
dnp
mmusv
activ
id
network
viral
antigen
similarli
achiev
result
product
idand
antigenspecif
antibodi
antigenspecif
antibodi
term
ab
frequent
shown
protect
pathogen
challeng
provid
evid
role
id
network
activ
antibodi
alon
immunotherapeut
treatment
virusinduc
tumorassoci
antigen
virus
associ
infecti
diseas
